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Explanatory mechanisms for the association between poor exercise capacity and infections following surgery are underexplored.
We hypothesized that aerobic fitness—assessed by cardiopulmonary exercise testing (CPET)—would be associated with circulating
inflammatory markers, as quantified by the neutrophil-lymphocyte ratio (NLR) and monocyte subsets. The association between
cardiopulmonary reserve and inflammation was tested by multivariable regression analysis with covariates including anaerobic
threshold (AT) and malignancy. In a first cohort of 240 colorectal patients, AT was identified as the sole factor associated with
higher NLR (𝑃 = 0.03) and absolute and relative lymphopenia (𝑃 = 0.01). Preoperative leukocyte subsets and monocyte CD14+
expression (downregulated by endotoxin and indicative of chronic inflammation) were also assessed in two further cohorts of
age-matched elective gastrointestinal and orthopaedic surgical patients. Monocyte CD14+ expression was lower in gastrointestinal
patients (𝑛 = 43) compared to age-matched orthopaedic patients (𝑛 = 31). The circulating CD14+CD16− monocyte subset was
reduced in patients with low cardiopulmonary reserve. Poor exercise capacity in patients without a diagnosis of heart failure is
independently associated with markers of inflammation. These observations suggest that preoperative inflammation associated
with impaired cardiorespiratory performance may contribute to the pathophysiology of postoperative outcome.
1. Introduction
Immune dysregulation is a key feature of low cardiac output
states. Absolute numbers, as well as function, of monocytes
and T-cells are markedly altered in cardiac failure [1]. Severe
heart failure is associated with higher levels of circulating
endotoxin [2] and lymphopenia [3]. Systemic inflammation
driven by exposure to endotoxin in patients with heart failure
results in downregulation ofmonocyte CD14+ expression and
increased soluble CD14 through shedding of this receptor
from the cellular membrane. Alterations in three distinct
CD14+monocyte subsets occur in various pathophysiological
states, as defined by CD16 (Fc𝛾RIII) expression.The function
of these subsets appears to be highly context-specific, with
CD16+ subsets frequently expanded in chronic inflamma-
tory conditions. Notably, in patients with chronic systolic
heart failure, the nonclassical CD14dimCD16+ subset is more
prevalent and inversely associated with worsening cardiac
performance [4]. By contrast, reduced levels of the classical
CD14++CD16− monocyte subset are reported in heart failure,
compatible with remodelling roles for different subsets [5].
Poor exercise capacity in surgical patients, as measured
objectively by preoperative cardiopulmonary exercise [6–
12], is associated with poorer postoperative outcomes—
including infection—following surgery [13]. Plausible mech-
anisms that explain the link between poor exercise capacity
and poorer postoperative outcomes remain underexplored.
Whether preoperative exercise capacity in surgical patients is
similarly independently linked to markers of inflammation,
as reported in heart failure, remains unclear. We there-
fore hypothesized that impaired cardiovascular performance
(as defined by cardiopulmonary exercise testing) would be
associated with biomarkers for inflammation (neutrophil-
lymphocyte ratio and absolute and relative lymphopenia)
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and/or evidence consistent with surfacemarkers indicative of
changes in monocyte function by circulating endotoxin.
2. Materials and Methods
2.1. Patient Populations. Patients undergoing major elec-
tive colorectal surgery, including those who were screened
for the COMPETE-C randomized controlled trial [14],
underwent CPET at Derriford Hospital, Plymouth, UK, as
approved by the Cornwall and Plymouth Research Ethics
Committee (Medical Research Ethics Committee (MREC):
08/H0203/159). Full details of this trial (including CON-
SORT information) have been reported previously [14].
Further preoperative immune analysis was undertaken in two
Research Ethics Committee approved studies at University
College London Hospitals enrolling elective orthopaedic
patients, healthy volunteers (MREC: 09/H0805/59), and
patients undergoing major gastrointestinal surgery (MREC:
09/H0805/58). Adherence to STROBE guidelines is doc-
umented in Table S1 in Supplementary Material available
online at http://dx.doi.org/10.1155/2014/727451.
2.2. Cardiopulmonary Exercise Testing. Patients completed
symptom-limited maximal cardiopulmonary exercise testing
(CPET) as part of their routine preoperative assessment.
Following a period of 2min rest and 2min unloaded ped-
alling, patients began ramped, continuous incremental, and
symptom limited exercise on a stationary ergometer (Zan,
nSpire, CO, USA), with a ramp gradient 15–20W/minute.
CPET was stopped as determined by the patients’ toler-
ance. Ventilation and gas exchange variables were measured
using a metabolic cart (Zan, nSpire, CO, USA). 12-lead
electrocardiogram, noninvasive blood pressure, and pulse
oximetry were monitored throughout the test period. Anaer-
obic threshold (AT) was used as themarker of aerobic fitness.
AT was determined by two independent assessors according
to the published guidelines using V-slope and confirmed by
ventilatory equivalents [15].
Experiment 1 (differential leukocyte counts). Preoperative
blood samples were used to assess leukocyte subsets in both
centres (Sysmex XE2100 analyzer, Sysmex, Milton Keynes,
UK).
Experiment 2 (flow cytometry assessment of monocytes).
Heparinised blood samples were collected in heparin from
preoperative patients at the same time of day, who had
fasted for at least 6 h. All patients were undergoing elec-
tive surgery and were free from infection. Flow cytometry
(Cyan ADP cytometer, Beckman Coulter, High Wycombe,
UK) was performed using 100 𝜇L of freshly obtained whole
blood samples placed on ice immediately after collection
and processed in accordance with published guidelines [16].
Samples were processed within 2 h of collection. Control
beads were used prior to each run. CD14+ expression was
quantified in monocytes identified by forward and side scat-
ter characteristics, combined with HLA-DR surface expres-
sion. Antibodies for CD14, CD16, and HLA-DR were pur-
chased fromMiltenyi Biotec, UK. Respective murine isotype
controls (IgG2a and IgM, resp.; Miltenyi Biotec, UK) were
used for each surface marker. Fc receptor blocker was used
routinely. After incubation for 20 minutes, samples were
fixed with 2% paraformaldehyde and red blood cells were
lysed using isotonic ammonium chloride buffer. At least
10000 gated events were captured. Flow cytometry data
were analyzed using Kaluza software (version 1.2; Beckman
Coulter, High Wycombe, UK). Using an established gating
strategy [17], three distinct subsets that are altered in various
pathophysiological states of CD14+ monocyte subsets were
identified by CD16 (Fc𝛾RIII) expression.
2.3. Statistics. To test the association between cardiopul-
monary limitation and preoperative inflammation, multiple
regression analysis (1-way hierarchical switching model)
was undertaken with NLR as the dependent variable. AT
was entered as a continuous independent variable with the
following categorical independent variables: risk factors for
cardiovascular disease [18], presence of malignancy, age, and
gender. The relationship between a preoperative neutrophil-
lymphocyte ratio>2.8—which is predictive of overall survival
following colorectal surgery—and AT was also assessed
(Fisher’s exact test) [19]. For continuous data, variables were
analysed with ANCOVA. Nonparametric data were analysed
with the Mann-Whitney 𝑈 test. All reported 𝑃 values are
two-sided. Statistical analyses were performed using NCSS 8
(Kaysville, UT, USA).
2.4. Sample Size Calculations. We powered the primary
outcome (NLR) on the basis that ∼30% colorectal patients
with low AT (<11mL⋅kg−1⋅min−1) [13] would exhibit a prog-
nostically significant difference in NLR ≥0.5 [20–23], with an
anticipated standard deviation of 1.0.Thus,≥185 patients with
AT > 11mL⋅kg−1⋅min−1, compared with ≥56 patients with low
AT (alpha = 0.05; power = 90%). Based on preceding studies
in the cardiac failure literature measuring soluble CD14
[24], we sought to find an absolute difference in monocyte
CD14 median fluorescence intensity of 25 arbitrary units
(anticipated standard deviation of 25 arbitrary units), thus
requiring a sample size of ≥32 cases per group (𝛼 = 0.01;
power = 90%).
3. Results
Experiment 1 (CPET physiological characteristics and leuko-
cyte subsets). Demographics and associated cardiopul-
monary test parameters of patients undergoing preoperative
CPET are shown in Table 1.Themajority of anaerobic thresh-
old values were consistent with those reported for NYHA
Classes 3-4 (Figure 1). Impaired cardiovascular performance
was associated independently with higher NLR (𝑃 = 0.04)
and absolute (𝑃 = 0.007) and relative lymphopenia (𝑃 =
0.004), adjusted for the presence of malignancy. Unadjusted
for malignancy, low AT was associated with higher NLR (low
AT: +0.54 (95% CI: 0.1–0.98); 𝑃 = 0.01) and absolute (low
AT: −0.20 lymphocytes 109mL−1 (95% CI: 0.01–0.40); 𝑃 =
0.04) and relative lymphopenia (low AT: −3.4% (95% CI:
1.05–5.79); 𝑃 = 0.005; Figure 2).
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Table 1: CPET demographics in colorectal surgery cohort, stratified according to the prognostically relevant anaerobic threshold
<11mL kg−1 min−1 and >11mL kg−1 min−1 .
VAT < 11mL kg−1min-1 VAT > 11mL kg−1min−1 𝑃 value
Number 79 161
Age (y) 71 (69–73) 63 (61–66) 0.0001
Gender (male : female ratio) 1.05 1.47 0.30
Cancer (𝑛; %) 66 (86%) 114 (72%) 0.02
Chemotherapy (𝑛; %) 21 (13%) 11 (14%) 0.82
Body mass index (kgm2) 29.6 (28.5–30.6) 27.4 (26.7–28.0) 0.0004
V̇E/V̇CO2 30.3 (28.9–31.7) 27.8 (27.2–28.5) 0.0004
Peak V̇O2 (mL kg
−1 min−1) 14.8 (13.9–15.6) 22.5 (21.5–23.4) <0.0001
Data are presented as mean (95% confidence intervals), unless stated otherwise.
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Figure 1: Histogram showing numbers of patients (𝑛 = 240)
stratified by AT-definedNYHA class. Cutoff values for AT estimated
from recent published series [25, 26].
Controlling for the presence of malignancy (present in
77% of patients), low AT remained associated with higher
NLR (low AT: +0.54 (95% CI: 0.1–0.98); 𝑃 = 0.01) and
absolute (low AT: −0.20 lymphocytes 109⋅mL−1 (95% CI:
0.01–0.40); 𝑃 = 0.04) and relative (low AT: −3.4% (95%
CI: 1.05–5.79); 𝑃 = 0.005) lymphopenia, with no signif-
icant interaction observed between malignancy and AT <
11mL⋅kg−1⋅min−1 (𝑃 = 0.29). Multiple regression analysis
identified AT as the sole factor associated with higher NLR
(𝑃 = 0.033). An AT < 11mL⋅kg−1⋅min−1 was strongly
associated with a preoperative NLR reported to be predictive
of survival postoperatively (relative risk: 1.9 (95% confidence
intervals: 1.4–2.5); 𝑃 = 0.01) [19].
Experiment 2 (preoperative monocyte CD14+ expression).
Next, we assessed whether age-matched patients free of
malignancy showed any evidence for systemic inflammation
as indicated by biomarker levels found in patients undergoing
colorectal surgery. We reasoned that monocyte CD14 sur-
face expression would be reduced in patients with low AT,
compared to age-matched controls with no clinical evidence
for cardiac failure. Preoperative neutrophil-lymphocyte ratio
was higher (𝑃 = 0.01), and monocyte CD14+ expression
was lower (−112 median fluorescence units (95% CI: 49–176);
𝑃 = 0.002) in 38 patients undergoing major surgery for
gastrointestinal malignancy (median AT: 10mL⋅kg−1⋅min−1
(IQR 9–11)), compared to age-matched orthopaedic patients
(𝑛 = 31) without overt clinical heart failure (Figures 3(a) and
3(b)). CD14+ monocyte subset analysis (Figure 3(c)) showed
that the CD14+CD16− subset was reduced in patients with
low cardiopulmonary reserve (Figure 3(d)).
4. Discussion
Our data show that impaired cardiovascular performance as
measured by CPET is associated with changes in leukocyte
subsets that have emerged as robust prognostic markers
of colorectal surgical outcome. Consistent with these data,
we also found that downregulation of monocyte CD14+
expression and lymphopenia were associated with impaired
cardiorespiratory reserve.
Maintenance, or enhancement, of exercise capacity has
been associated with a range of beneficial immune responses
[27]. Habitual exercise is associated with improved immune
responses to vaccination [28] and outcomes following viral
infections [29] and malignancy [30]. Immune dysregulation
is a pivotal feature of poor aerobic capacity [1], with the
most severe grades of heart failure associated with higher
levels of circulating endotoxin [2] and lymphopenia [3].
Our data suggest that in higher-risk surgical patients similar
immune dysregulation may occur, even though such patients
have never received a formal diagnosis of cardiac failure.
Since the presence of overt cardiac failure is an important
prognostic factor in determining postoperative outcome [31],
our data also suggest that dysregulation of inflammation is
associated with poor cardiopulmonary reserve in preopera-
tive patients. Preexisting inflammation could contribute to
increased morbidity andmortality after surgery—in addition
to any putative mechanistic role for impaired perioperative
cardiovascular performance. Interestingly, several studies
have reported an association between preoperative NLR and
postoperative complications [19–23] but have not made the
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Figure 2: Leukocyte subsets according to AT value associated with poorer postoperative outcomes. (a) White cell count. (b) Neutrophil-
lymphocyte ratio. (c)Absolute neutrophil count. (d)Absolute lymphocyte count. (e)Absolutemonocyte count. (f) Proportion of lymphocytes.
(g) Proportion of neutrophils. (h) Proportion of monocytes. All data are represented as mean ± SD; 𝑛 = 240 patients.
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Figure 3: Monocyte CD14+ expression. (a) Representative HLA-DR+ CD14+ expression (median fluorescence intensity) in orthopedic
(blue) and gastrointestinal (red) surgical patients. Isotype control shown in grey. (b) Summary data for orthopedic (𝑛 = 43 patients) and
gastrointestinal malignancy (𝑛 = 31 patients). (c) Gating strategy to define HLA-DR+ CD14+monocyte subsets, including CD16+cells. (d)
Proportions of monocyte CD14+ subsets according to CD16+ expression. All data are represented as median (IQR).
link with another strong predictor of postoperative mor-
bidity—aerobic performance. Taken together, these data sug-
gest that low AT may therefore be a marker, rather than a
direct mediator, of poorer perioperative outcomes.
Experimental and clinical data suggest that established
immune dysfunction is instrumental in driving impaired
cardiovascular function, rather than merely being a marker
of disease progression [1]. Thus, targeting immune function
is an increasingly important line of investigation in efforts to
reduce the substantial mortality from the increasing preval-
ence of cardiac failure. Strikingly, similar data from the peri-
operative literature supports this concept: patients with evi-
dence for preoperative depletion of antibodies to endotoxin
exhibit higher levels of proinflammatory cytokines and sus-
tain more perioperative morbidity [32, 33]. Downregulation
of CD14+ is consistent with the hypothesis that chronic
systemic exposure to low plasma levels of endotoxin occurs as
a result of (occult) cardiac failure [34, 35]. Alternatively, these
data may reflect gastrointestinal pathology and endotoxin
“leak” [36]. Nevertheless, our results are consistent with pre-
vious studies reporting that the CD14++CD16− monocyte
subset was reduced in patients with chronic systolic heart fail-
ure [34].
Monocyte-macrophage function is altered by exercise-
induced activation of both sympathetic and hypothalamic-
pituitary axes [37]. Absolute monocyte count transiently
increases in response to acute exercise, accompanied by
preferential demarginalization of the proinflammatory
CD14+CD16+ subset [38] and downregulation of Toll-like
receptors [39]. After cessation of exercise, the CD14+CD16+
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subset declines—indicative of remarginalization or recruit-
ment to tissue [40]. Sustained exercise is associated with
reduced circulating monocyte inflammatory responses to
lipopolysaccharide, lower TLR4 expression, and a lower
percentage of the proinflammatory CD14+CD16+ [41].
Human data regarding the impact of chronic exercise on,
as well as tissue resident function of, monocyte function
is limited. However, murine models suggest that exercise-
trained mice demonstrate enhanced splenic macrophage
proliferative capacity and peritonealmacrophages phagocytic
activity [42]. Patients with more advanced heart failure, as
reflected by low AT, demonstrate an increased number of
neutrophils. This relative neutrophilia is accompanied by a
decreased number of lymphocytes, characterised by higher
proportions of terminally differentiated CD4+ and CD8+
T-subsets [43]. These data are consistent with molecular
mechanisms driving a T-cell immunosenescent state [44].
We acknowledge several limitations of this exploratory
study. Further detailed analyses of leukocyte subset func-
tionality stratified by AT could be instructive; in particular,
CD14+ subsets associated with an augmented proinflamma-
tory phenotype or different migratory properties require fur-
ther elucidation.Measurement of endotoxin levels would add
further insight. The association between NLR and coronary
artery disease [45] may reveal mechanistic links to periop-
erative outcomes, including myocardial injury. Ultimately,
detailed outcome data—including propensity to infectious
complications—will test the hypothesis further that low AT
may be associated with defective innate and/or adaptive
immune functionality.
In summary, impaired cardiovascular performance is
associated with changes in leukocyte subsets that have
emerged as robust prognostic markers of colorectal surgical
outcome. Consistent with these data, we also find that down-
regulation of monocyte CD14+ expression and lymphopenia
are associated with impaired cardiorespiratory reserve.These
observations suggest that preoperative inflammation, associ-
ated with impaired cardiorespiratory performance, may con-
tribute a pathophysiological role in determining postopera-
tive outcome.
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